共 419 条
[11]
Rimm DL(1998)Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells J Immunol 161 2833-5891
[12]
Cohn AL(2010)A first-in-human study of conatumumab in adult patients with advanced solid tumors Clin Cancer Res 16 5883-8591
[13]
Tabernero J(2005)Perturbation of the tumor necrosis factor–related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5 Clin Cancer Res 11 8585-195
[14]
Maurel J(1997)Inhibition of death receptor signals by cellular FLIP Nature 388 190-346
[15]
Nowara E(2000)Molecular determinants of response to TRAIL in killing of normal and cancer cells Clin Cancer Res 6 335-2842
[16]
Sastre J(2012)A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer Ann Oncol 23 2834-847
[17]
Chuah BY(1998)Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844-314
[18]
Kopp MV(2003)Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer Apmis 111 309-559
[19]
Sakaeva DD(2000)Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes Cancer Res 60 553-848
[20]
Mitchell EP(2006)c-FLIP inhibits chemotherapy-induced colorectal cancer cell death Oncogene 25 838-639